Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
GABA Receptor Agonist Drug market report explains the definition, types, applications, major countries, and major players of the GABA Receptor Agonist Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Pfizer
Elan Corporation
AstraZeneca
GlaxoSmithKline
Advicenne
XenoPort
Biocodex
Athena Drug Delivery Solutions
Eli Lilly and Company
NovaDel Pharma
Novartis
OVATION Pharmaceuticals
HLundBeck, Merck and Co
sanofi-aventis
Osmotica Pharmaceutical
VIVUS
By Type:
Bamaluzole
Phenibut
Baclofen
Gaboxadol
Klonopin (clonazepam)
Tiagbine
By End-User:
Attention Deficit Hyperactivity Disorder (ADHD)
Psychiatric Disorders and Depression
Alzheimer
Epilepsy and Seizure
Anxiety and Sleep Disorders
Obesity and Alcoholism
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global GABA Receptor Agonist Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 GABA Receptor Agonist Drug Outlook to 2028- Original Forecasts
-
2.2 GABA Receptor Agonist Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term GABA Receptor Agonist Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global GABA Receptor Agonist Drug Market- Recent Developments
-
6.1 GABA Receptor Agonist Drug Market News and Developments
-
6.2 GABA Receptor Agonist Drug Market Deals Landscape
7 GABA Receptor Agonist Drug Raw Materials and Cost Structure Analysis
-
7.1 GABA Receptor Agonist Drug Key Raw Materials
-
7.2 GABA Receptor Agonist Drug Price Trend of Key Raw Materials
-
7.3 GABA Receptor Agonist Drug Key Suppliers of Raw Materials
-
7.4 GABA Receptor Agonist Drug Market Concentration Rate of Raw Materials
-
7.5 GABA Receptor Agonist Drug Cost Structure Analysis
-
7.5.1 GABA Receptor Agonist Drug Raw Materials Analysis
-
7.5.2 GABA Receptor Agonist Drug Labor Cost Analysis
-
7.5.3 GABA Receptor Agonist Drug Manufacturing Expenses Analysis
8 Global GABA Receptor Agonist Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global GABA Receptor Agonist Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global GABA Receptor Agonist Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global GABA Receptor Agonist Drug Market Outlook by Types and Applications to 2022
-
9.1 Global GABA Receptor Agonist Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Bamaluzole Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Phenibut Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Baclofen Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Gaboxadol Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Klonopin (clonazepam) Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Tiagbine Consumption and Growth Rate (2017-2022)
-
9.2 Global GABA Receptor Agonist Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Psychiatric Disorders and Depression Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Alzheimer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Epilepsy and Seizure Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Anxiety and Sleep Disorders Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Obesity and Alcoholism Consumption and Growth Rate (2017-2022)
10 Region and Country-wise GABA Receptor Agonist Drug Market Analysis and Outlook till 2022
-
10.1 Global GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.2.2 Canada GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.2.3 Mexico GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.3.2 UK GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.3.3 Spain GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.3.4 Belgium GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.3.5 France GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.3.6 Italy GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.3.7 Denmark GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.3.8 Finland GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.3.9 Norway GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.3.10 Sweden GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.3.11 Poland GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.3.12 Russia GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.3.13 Turkey GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.4.2 Japan GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.4.3 India GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.4.4 South Korea GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.4.5 Pakistan GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.4.6 Bangladesh GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.4.7 Indonesia GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.4.8 Thailand GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.4.9 Singapore GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.4.10 Malaysia GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.4.11 Philippines GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.4.12 Vietnam GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.5.2 Colombia GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.5.3 Chile GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.5.4 Argentina GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.5.5 Venezuela GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.5.6 Peru GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.5.8 Ecuador GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.6.2 Kuwait GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.6.3 Oman GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.6.4 Qatar GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.7.2 South Africa GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.7.3 Egypt GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.7.4 Algeria GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia GABA Receptor Agonist Drug Consumption (2017-2022)
-
10.8.2 New Zealand GABA Receptor Agonist Drug Consumption (2017-2022)
11 Global GABA Receptor Agonist Drug Competitive Analysis
-
11.1 Pfizer
-
11.1.1 Pfizer Company Details
-
11.1.2 Pfizer GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Pfizer GABA Receptor Agonist Drug Main Business and Markets Served
-
11.1.4 Pfizer GABA Receptor Agonist Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Elan Corporation
-
11.2.1 Elan Corporation Company Details
-
11.2.2 Elan Corporation GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Elan Corporation GABA Receptor Agonist Drug Main Business and Markets Served
-
11.2.4 Elan Corporation GABA Receptor Agonist Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 AstraZeneca
-
11.3.1 AstraZeneca Company Details
-
11.3.2 AstraZeneca GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 AstraZeneca GABA Receptor Agonist Drug Main Business and Markets Served
-
11.3.4 AstraZeneca GABA Receptor Agonist Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 GlaxoSmithKline
-
11.4.1 GlaxoSmithKline Company Details
-
11.4.2 GlaxoSmithKline GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 GlaxoSmithKline GABA Receptor Agonist Drug Main Business and Markets Served
-
11.4.4 GlaxoSmithKline GABA Receptor Agonist Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Advicenne
-
11.5.1 Advicenne Company Details
-
11.5.2 Advicenne GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Advicenne GABA Receptor Agonist Drug Main Business and Markets Served
-
11.5.4 Advicenne GABA Receptor Agonist Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 XenoPort
-
11.6.1 XenoPort Company Details
-
11.6.2 XenoPort GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 XenoPort GABA Receptor Agonist Drug Main Business and Markets Served
-
11.6.4 XenoPort GABA Receptor Agonist Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Biocodex
-
11.7.1 Biocodex Company Details
-
11.7.2 Biocodex GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Biocodex GABA Receptor Agonist Drug Main Business and Markets Served
-
11.7.4 Biocodex GABA Receptor Agonist Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Athena Drug Delivery Solutions
-
11.8.1 Athena Drug Delivery Solutions Company Details
-
11.8.2 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Main Business and Markets Served
-
11.8.4 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Eli Lilly and Company
-
11.9.1 Eli Lilly and Company Company Details
-
11.9.2 Eli Lilly and Company GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Eli Lilly and Company GABA Receptor Agonist Drug Main Business and Markets Served
-
11.9.4 Eli Lilly and Company GABA Receptor Agonist Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 NovaDel Pharma
-
11.10.1 NovaDel Pharma Company Details
-
11.10.2 NovaDel Pharma GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 NovaDel Pharma GABA Receptor Agonist Drug Main Business and Markets Served
-
11.10.4 NovaDel Pharma GABA Receptor Agonist Drug Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Novartis
-
11.11.1 Novartis Company Details
-
11.11.2 Novartis GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Novartis GABA Receptor Agonist Drug Main Business and Markets Served
-
11.11.4 Novartis GABA Receptor Agonist Drug Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 OVATION Pharmaceuticals
-
11.12.1 OVATION Pharmaceuticals Company Details
-
11.12.2 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Main Business and Markets Served
-
11.12.4 OVATION Pharmaceuticals GABA Receptor Agonist Drug Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 HLundBeck, Merck and Co
-
11.13.1 HLundBeck, Merck and Co Company Details
-
11.13.2 HLundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 HLundBeck, Merck and Co GABA Receptor Agonist Drug Main Business and Markets Served
-
11.13.4 HLundBeck, Merck and Co GABA Receptor Agonist Drug Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 sanofi-aventis
-
11.14.1 sanofi-aventis Company Details
-
11.14.2 sanofi-aventis GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 sanofi-aventis GABA Receptor Agonist Drug Main Business and Markets Served
-
11.14.4 sanofi-aventis GABA Receptor Agonist Drug Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Osmotica Pharmaceutical
-
11.15.1 Osmotica Pharmaceutical Company Details
-
11.15.2 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Main Business and Markets Served
-
11.15.4 Osmotica Pharmaceutical GABA Receptor Agonist Drug Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 VIVUS
-
11.16.1 VIVUS Company Details
-
11.16.2 VIVUS GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 VIVUS GABA Receptor Agonist Drug Main Business and Markets Served
-
11.16.4 VIVUS GABA Receptor Agonist Drug Product Portfolio
-
11.16.5 Recent Research and Development Strategies
12 Global GABA Receptor Agonist Drug Market Outlook by Types and Applications to 2028
-
12.1 Global GABA Receptor Agonist Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Bamaluzole Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Phenibut Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Baclofen Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Gaboxadol Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Klonopin (clonazepam) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Tiagbine Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global GABA Receptor Agonist Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Psychiatric Disorders and Depression Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Alzheimer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Epilepsy and Seizure Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Anxiety and Sleep Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Obesity and Alcoholism Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise GABA Receptor Agonist Drug Market Analysis and Outlook to 2028
-
13.1 Global GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.3.2 UK GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.3.5 France GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.4.3 India GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of GABA Receptor Agonist Drug
-
Figure of GABA Receptor Agonist Drug Picture
-
Table Global GABA Receptor Agonist Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global GABA Receptor Agonist Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Bamaluzole Consumption and Growth Rate (2017-2022)
-
Figure Global Phenibut Consumption and Growth Rate (2017-2022)
-
Figure Global Baclofen Consumption and Growth Rate (2017-2022)
-
Figure Global Gaboxadol Consumption and Growth Rate (2017-2022)
-
Figure Global Klonopin (clonazepam) Consumption and Growth Rate (2017-2022)
-
Figure Global Tiagbine Consumption and Growth Rate (2017-2022)
-
Figure Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption and Growth Rate (2017-2022)
-
Figure Global Psychiatric Disorders and Depression Consumption and Growth Rate (2017-2022)
-
Figure Global Alzheimer Consumption and Growth Rate (2017-2022)
-
Figure Global Epilepsy and Seizure Consumption and Growth Rate (2017-2022)
-
Figure Global Anxiety and Sleep Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Obesity and Alcoholism Consumption and Growth Rate (2017-2022)
-
Figure Global GABA Receptor Agonist Drug Consumption by Country (2017-2022)
-
Table North America GABA Receptor Agonist Drug Consumption by Country (2017-2022)
-
Figure United States GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Table Europe GABA Receptor Agonist Drug Consumption by Country (2017-2022)
-
Figure Germany GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure UK GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure France GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Table APAC GABA Receptor Agonist Drug Consumption by Country (2017-2022)
-
Figure China GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure India GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Table South America GABA Receptor Agonist Drug Consumption by Country (2017-2022)
-
Figure Brazil GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Table GCC GABA Receptor Agonist Drug Consumption by Country (2017-2022)
-
Figure Bahrain GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Table Africa GABA Receptor Agonist Drug Consumption by Country (2017-2022)
-
Figure Nigeria GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania GABA Receptor Agonist Drug Consumption by Country (2017-2022)
-
Figure Australia GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Table Pfizer Company Details
-
Table Pfizer GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer GABA Receptor Agonist Drug Main Business and Markets Served
-
Table Pfizer GABA Receptor Agonist Drug Product Portfolio
-
Table Elan Corporation Company Details
-
Table Elan Corporation GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Elan Corporation GABA Receptor Agonist Drug Main Business and Markets Served
-
Table Elan Corporation GABA Receptor Agonist Drug Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca GABA Receptor Agonist Drug Main Business and Markets Served
-
Table AstraZeneca GABA Receptor Agonist Drug Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline GABA Receptor Agonist Drug Main Business and Markets Served
-
Table GlaxoSmithKline GABA Receptor Agonist Drug Product Portfolio
-
Table Advicenne Company Details
-
Table Advicenne GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Advicenne GABA Receptor Agonist Drug Main Business and Markets Served
-
Table Advicenne GABA Receptor Agonist Drug Product Portfolio
-
Table XenoPort Company Details
-
Table XenoPort GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table XenoPort GABA Receptor Agonist Drug Main Business and Markets Served
-
Table XenoPort GABA Receptor Agonist Drug Product Portfolio
-
Table Biocodex Company Details
-
Table Biocodex GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocodex GABA Receptor Agonist Drug Main Business and Markets Served
-
Table Biocodex GABA Receptor Agonist Drug Product Portfolio
-
Table Athena Drug Delivery Solutions Company Details
-
Table Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Athena Drug Delivery Solutions GABA Receptor Agonist Drug Main Business and Markets Served
-
Table Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product Portfolio
-
Table Eli Lilly and Company Company Details
-
Table Eli Lilly and Company GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company GABA Receptor Agonist Drug Main Business and Markets Served
-
Table Eli Lilly and Company GABA Receptor Agonist Drug Product Portfolio
-
Table NovaDel Pharma Company Details
-
Table NovaDel Pharma GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table NovaDel Pharma GABA Receptor Agonist Drug Main Business and Markets Served
-
Table NovaDel Pharma GABA Receptor Agonist Drug Product Portfolio
-
Table Novartis Company Details
-
Table Novartis GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis GABA Receptor Agonist Drug Main Business and Markets Served
-
Table Novartis GABA Receptor Agonist Drug Product Portfolio
-
Table OVATION Pharmaceuticals Company Details
-
Table OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table OVATION Pharmaceuticals GABA Receptor Agonist Drug Main Business and Markets Served
-
Table OVATION Pharmaceuticals GABA Receptor Agonist Drug Product Portfolio
-
Table HLundBeck, Merck and Co Company Details
-
Table HLundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table HLundBeck, Merck and Co GABA Receptor Agonist Drug Main Business and Markets Served
-
Table HLundBeck, Merck and Co GABA Receptor Agonist Drug Product Portfolio
-
Table sanofi-aventis Company Details
-
Table sanofi-aventis GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table sanofi-aventis GABA Receptor Agonist Drug Main Business and Markets Served
-
Table sanofi-aventis GABA Receptor Agonist Drug Product Portfolio
-
Table Osmotica Pharmaceutical Company Details
-
Table Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Osmotica Pharmaceutical GABA Receptor Agonist Drug Main Business and Markets Served
-
Table Osmotica Pharmaceutical GABA Receptor Agonist Drug Product Portfolio
-
Table VIVUS Company Details
-
Table VIVUS GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table VIVUS GABA Receptor Agonist Drug Main Business and Markets Served
-
Table VIVUS GABA Receptor Agonist Drug Product Portfolio
-
Figure Global Bamaluzole Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Phenibut Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Baclofen Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gaboxadol Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Klonopin (clonazepam) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tiagbine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psychiatric Disorders and Depression Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alzheimer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Epilepsy and Seizure Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anxiety and Sleep Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Obesity and Alcoholism Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GABA Receptor Agonist Drug Consumption Forecast by Country (2022-2028)
-
Table North America GABA Receptor Agonist Drug Consumption Forecast by Country (2022-2028)
-
Figure United States GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe GABA Receptor Agonist Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC GABA Receptor Agonist Drug Consumption Forecast by Country (2022-2028)
-
Figure China GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America GABA Receptor Agonist Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC GABA Receptor Agonist Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa GABA Receptor Agonist Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania GABA Receptor Agonist Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
